首页 | 本学科首页   官方微博 | 高级检索  
     

基于真实世界数据的中成药安全性评价模式构建
引用本文:李玲,刘艳梅,谭婧,王雯,姚明宏,马玉,罗小超,廖星,刘岩,宋海波,温泽淮,孙鑫. 基于真实世界数据的中成药安全性评价模式构建[J]. 中国药物警戒, 2022, 0(1): 18-22
作者姓名:李玲  刘艳梅  谭婧  王雯  姚明宏  马玉  罗小超  廖星  刘岩  宋海波  温泽淮  孙鑫
作者单位:四川大学华西医院中国循证医学中心;国家药品监督管理局海南真实世界数据研究与评价重点实验室;四川省真实世界数据技术创新中心;中国中医科学院中医临床基础医学研究所;北京中医药大学东直门医院中医内科学教育部和北京市重点实验室;国家药品监督管理局药品评价中心;广东省中医院临床研究方法学重点研究室
基金项目:国家重点研发计划(2017YFC1700406,2019YFC1709804);国家自然科学基金青年科学基金项目(71904134);四川省青年科技创新研究团(2020JDTD0015);中国中医药循证医学中心“业务研究室主任专项”(2020YJSZX-3);四川大学华西医院学科卓越发展1?3?5工程项目(ZYYC08003)。
摘    要:目的 构建基于真实世界数据的中成药安全性评价模式,为研究者和决策者正确生产和使用基于真实世界数据的中成药安全性评价证据提供参考.方法 通过查阅国内外文献总结真实世界数据在中成药安全性评价中的作用,探索构建基于真实世界数据的中成药安全性评价模式.结果 从药品监管的角度,提出了基于常规收集和主动收集的真实世界数据开展中成药...

关 键 词:真实世界数据  中成药  安全性  评价

Developing a safety assessment model for Chinese patent medicines based on real-world data
LI Ling,LIU Yanmei,TAN Jing,WANG Wen,YAO Minghong,MA Yu,LUO Xiaochao,LIAO Xing,LIU Yan,SONG Haibo,WEN Zehuai,SUN Xin. Developing a safety assessment model for Chinese patent medicines based on real-world data[J]. Chinese JOurnal of Pharmacovigilance, 2022, 0(1): 18-22
Authors:LI Ling  LIU Yanmei  TAN Jing  WANG Wen  YAO Minghong  MA Yu  LUO Xiaochao  LIAO Xing  LIU Yan  SONG Haibo  WEN Zehuai  SUN Xin
Affiliation:(Chinese Evidence-based Medicine Center,West China Hospital,Sichuan University,Chengdu Sichuan 610041,China;NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan,Haikou Hainan 570100,China;Sichuan Center of Technology Innovation for Real World Data,Chengdu Sichuan 610041,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Key Laboratory of Chinese Internal Medicine of Ministry of Education,Beijing Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China;Center for Drug Reevaluation,NMPA/NMPA Key Laboratory for Research and Evaluation of Pharmacovigilance,Beijing 100022,China;Key Unit of Methodology in Clinical Research,Guangdong Provincial Hospital of Chinese Medicine,Guangzhou Guangdong 510120,China)
Abstract:Objective To develop a safety assessment model for Chinese patent medicines based on real-word data,so as to provide reference for researchers and decision makers to scientifically and rationally produce and use real-world-data-based safety assessment evidence of Chinese patent medicines.Methods We summarized the role of real-world data in the safety assessment of Chinese patent medicines by referring to domestic and foreign literatures,explored and developed the safety assessment model of Chinese patent medicines based on real-world data.Results We proposed,from the perspective of drug regulation,a safety assessment research model for Chinese patent medicines based on routinely collected and actively collected real-world data,and its application was illustrated with an example.Conclusion Real-world data plays an important role in the safety assessment of Chinese patent medicines,but there are still some limitations.There is an urgent need to introduce new study design and statistical analysis methods in this field.
Keywords:real-world data  Chinese patent medicine  safety  assessment
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号